Core One Labs Inc. Stock
€0.43
Your prediction
Financial data and news for Core One Labs Inc.
sharewise wants to provide you with the best news and tools for Core One Labs Inc., so we directly link to the best financial data sources.
Financials
News

Core One Labs’ Akome Receives Positive Results from Bioassay Studies
Will Look to Advance its Psychedelic Based Formulations
Vancouver, British Columbia, Canada - April 2, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU)

Core One’s Vocan Biotechnologies and Awakened Biosciences Collaborate to Advance Vocan’s Mass Production Capabilities
Vancouver, British Columbia, Canada - March 15, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that

Core One Labs Proceeds with Next Milestone Achievement: To Produce Psilocybin
Successful Breakthrough of Biosynthetic Psilocybin Production Method Progressing Quickly
Vancouver, British Columbia, Canada - March 12, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLAB

Core One Labs’ Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations
Vancouver, British Columbia, Canada - March 4, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that i

Core One Labs’ Announces Successful Proof-of-Concept for Biosynthetic N-methyltryptamine (NMT)
VANCOUVER, British Columbia, March 3, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”), is pleased to announce that its

Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT)
Vancouver, British Columbia, Canada – February 21, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce

Core One Labs Completes Strategic Acquisition of Awakened Biosciences and its Game-Changing Provisional Patents
Vancouver, British Columbia, Canada – February 11, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”), a life sciences

Core One Labs Expects Imminent Breakthrough to Produce NMT, Precursor to DMT
Vancouver, British Columbia, Canada – February 10, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that

Core One Labs’ Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone for the Progression of Psychedelic Health Care
Vancouver, British Columbia, Canada – February XX, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that

Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences
Vancouver, British Columbia, Canada – January 26, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that

Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin
Vancouver, British Columbia, Canada - January 21, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce tha

Core One Labs Special Investor Webcast Rescheduled to Friday, January 21, 2022
Vancouver, British Columbia, Canada - January 18, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) announces that the special

Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022
Vancouver, British Columbia, Canada - January 15, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce, as

Core One Labs Now Also Working to Biosynthesize DMT and Receives License
Vancouver, British Columbia, Canada - January 08, 2022 - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce tha